MXPA01011267A - Derivados de 1,5-benzodiazepina. - Google Patents

Derivados de 1,5-benzodiazepina.

Info

Publication number
MXPA01011267A
MXPA01011267A MXPA01011267A MXPA01011267A MXPA01011267A MX PA01011267 A MXPA01011267 A MX PA01011267A MX PA01011267 A MXPA01011267 A MX PA01011267A MX PA01011267 A MXPA01011267 A MX PA01011267A MX PA01011267 A MXPA01011267 A MX PA01011267A
Authority
MX
Mexico
Prior art keywords
cck
compound
enantiomer
phenyl
acid
Prior art date
Application number
MXPA01011267A
Other languages
English (en)
Spanish (es)
Inventor
Jerzy Ryszard Szewczyk
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9910366.5A external-priority patent/GB9910366D0/en
Priority claimed from GBGB0008179.4A external-priority patent/GB0008179D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of MXPA01011267A publication Critical patent/MXPA01011267A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/12—1,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MXPA01011267A 1999-05-06 2000-05-04 Derivados de 1,5-benzodiazepina. MXPA01011267A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9910366.5A GB9910366D0 (en) 1999-05-06 1999-05-06 1,5-Benzodiazepine Derivatives
GBGB0008179.4A GB0008179D0 (en) 2000-04-05 2000-04-05 Chemical process
PCT/EP2000/003982 WO2000068209A2 (en) 1999-05-06 2000-05-04 1,5-benzodiazepine derivatives as cck-a receptor agonists

Publications (1)

Publication Number Publication Date
MXPA01011267A true MXPA01011267A (es) 2002-05-06

Family

ID=26244033

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA01011267A MXPA01011267A (es) 1999-05-06 2000-05-04 Derivados de 1,5-benzodiazepina.

Country Status (21)

Country Link
EP (1) EP1212305A2 (zh)
JP (1) JP2002544200A (zh)
KR (1) KR20020012567A (zh)
CN (1) CN1161345C (zh)
AR (1) AR022044A1 (zh)
AU (1) AU4754800A (zh)
BR (1) BR0010338A (zh)
CA (1) CA2370801A1 (zh)
CO (1) CO5170461A1 (zh)
CZ (1) CZ20013988A3 (zh)
HK (1) HK1046138A1 (zh)
HU (1) HUP0201181A3 (zh)
IL (1) IL146124A0 (zh)
MX (1) MXPA01011267A (zh)
MY (1) MY138319A (zh)
NO (1) NO20015397L (zh)
NZ (1) NZ515048A (zh)
PE (1) PE20010110A1 (zh)
PL (1) PL351546A1 (zh)
TR (1) TR200103169T2 (zh)
WO (1) WO2000068209A2 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005035793A2 (en) * 2003-10-09 2005-04-21 Decode Genetics Ehf. Cckar markers and haplotypes associated with extreme weight conditions
EA010888B1 (ru) 2004-05-25 2008-12-30 Пфайзер Продактс, Инк. Тетраазабензо[е]азуленовые производные и их аналоги
JP2022552655A (ja) 2019-10-07 2022-12-19 キャリーオペ，インク． Ｇｐｒ１１９アゴニスト

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9307833D0 (en) * 1993-04-15 1993-06-02 Glaxo Inc Modulators of cholecystokinin and gastrin

Also Published As

Publication number Publication date
KR20020012567A (ko) 2002-02-16
WO2000068209A3 (en) 2001-03-01
NO20015397D0 (no) 2001-11-05
NO20015397L (no) 2001-11-05
TR200103169T2 (tr) 2002-04-22
WO2000068209A2 (en) 2000-11-16
PL351546A1 (en) 2003-05-05
IL146124A0 (en) 2002-07-25
CN1362949A (zh) 2002-08-07
CN1161345C (zh) 2004-08-11
EP1212305A2 (en) 2002-06-12
HUP0201181A3 (en) 2003-10-28
BR0010338A (pt) 2002-02-13
HK1046138A1 (zh) 2002-12-27
CO5170461A1 (es) 2002-06-27
JP2002544200A (ja) 2002-12-24
NZ515048A (en) 2004-01-30
AU4754800A (en) 2000-11-21
PE20010110A1 (es) 2001-03-05
AR022044A1 (es) 2002-09-04
CZ20013988A3 (cs) 2002-02-13
MY138319A (en) 2009-05-29
HUP0201181A2 (hu) 2002-12-28
CA2370801A1 (en) 2000-11-16

Similar Documents

Publication Publication Date Title
US4880938A (en) Amino acid analogs
DE69426624T2 (de) 1,5 benzodiazepinoderivate mit cck-antagonisierender und oder agonisierender wirkung
AU2006298995B2 (en) Pyrazolo [1, 5 -alpha] pyrimidinyl derivatives useful as corticotropin-releasing factor (CRF) receptor antagonists
US5324726A (en) Benzodiazepine analogs
US5795887A (en) Method of inducing cholecystokinin agonist activity using 1,4- Benzodiazepine compounds
US5220017A (en) Cholecystokinin antagonists
US5451582A (en) Benzodiazepine derivatives, compositions containing them and their use in therapy
US5563136A (en) 3-Ureidobenzodiazepinones useful as antagonists of CCK or of gastrin
FR2723739A1 (fr) Derives de glycinamide, procedes pour leur preparation et medicaments les contenant.
US5302591A (en) Benzodiazepine derivatives
RU2135485C1 (ru) Производные 1,5-бензодиазепина и содержащий их фармацевтический состав
EP0667344A1 (fr) 3-acylamino-5-(phényl polysubstitué)-1,4-benzodiazépin-2-ones utiles comme abonistes du récepteur CCK
EP0984960B1 (fr) N-triazolyl-2-indolecarboxamides et leur utilisation comme agonistes de cck-a
US5639751A (en) N-acyl-2,3-benzodiazepine derivatives for treating acute and chronic neurodegenerative disorders
JPH08505120A (ja) ベンゾジアゼピン誘導体
DE69510545T2 (de) Cck oder gastrin modulierende 5-heterocyclicyl-1,5-benzodiazepine
US5521174A (en) N-acyl-2,3-benzodiazepine derivatives and a method of treating spasms of the skeletal musculature therewith
US5686449A (en) 1,5-benzodiazepines useful as gastrinor CCK-antagonists
RU2076100C1 (ru) Производные пиразола или их фармацевтически приемлемые соли
MXPA01011267A (es) Derivados de 1,5-benzodiazepina.
CZ267695A3 (en) 1,5-benzodiazepine derivatives, process of their preparation, their use and pharmaceutical preparations containing thereof
JPH0533701B2 (zh)
AU2004201385A1 (en) 1,5-benzodiazepine derivatives
US5378838A (en) Benzodiazepine cholecystokinin antagonists
ZA200108827B (en) 1,5-Benzodiazepine derivatives as CCK-A receptor agonists.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal